Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Calgene charges Enzo with interference

Calgene charges Enzo with interference

Calgene Inc. on Friday took preemptive action against Enzo Biochem Inc., filing suit to have ENZ's pending antisense patent declared invalid and not infringed

Read the full 316 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE